Featured Research

from universities, journals, and other organizations

Pioneering Study Looks At P53's Role In Tumor-stroma Interactions

Date:
October 27, 2006
Source:
Emory University Health Sciences Center
Summary:
Researchers have conducted the first comprehensive study of the role an important tumor suppressor gene plays in cancer development. P53 is known as a major tumor suppressor that is frequently mutated in human cancer. In this study, researchers used novel proteomic techniques to identify the proteins secreted by cells specifically in response to p53. The findings suggest a newfound role for wt-p53 in the control of the tumor's ability to communicate with the normal stromal cells surrounding it.

Researchers at Emory University's Winship Cancer Institute have conducted the first comprehensive study of the role an important tumor suppressor gene plays in cancer development.

Related Articles


P53 is known as a major tumor suppressor that is frequently mutated in human cancer. In this study, researchers used novel proteomic techniques to identify the proteins secreted by cells specifically in response to p53. The findings suggest a newfound role for wt-p53 in the control of the tumor's ability to communicate with the normal stromal cells surrounding it. The results of the study, "Proteomic identification of the wt-p53-regulated tumor cell secretome," are found in the October 9 advance online print of Oncogene.

"Cancer formation is traditionally thought of as a cell-autonomous process driven by mutations in genes that increase cell proliferation and survival, where a tumor is composed primarily of transformed cells," says Erwin G. Van Meir, PhD, Professor of Neurosurgery and Hematology/Oncology and lead-author of the study. "But increasing evidence suggests that the tumor microenvironment also contributes to neoplasm and that tumor-stroma interactions play a major role in tumor development, maintenance, and progression. A tumor is more like a casserole of chili than a bowl of white rice, where all the components in the mix interact. We need to better understand these tumor-stroma interactions to develop more effective cancer therapies."

But little is know about how the genetic changes that underlie cell transformation elicit extrinsic changes that modulate cell interactions. So, the researchers examined whether those events involve a modification in the cell's secreted proteins, which then act as mediators of intercellular communication.

Focusing on p53 as a proof-of-principle was a natural starting point as p53 is a transcription factor that directly controls the synthesis of numerous proteins. p53 is best known for its role in maintaining genomic integrity and cell survival in response to DNA damage. Yet some prior studies suggested that p53 could influence the tumor microenvironment by suppressing angiogenesis and tumor invasion.

To identify p53-regulated secreted proteins involved in intercellular communication, the researchers used a cell line derived from a malignant human glioma. The researchers found a total of 111 secreted proteins, 39 that showed enhanced secretion and 21 that showed inhibited secretion in response to wt-p53 expression. However, none of the proteins were found to be transcriptional targets, which suggests that wt-p53 may have an indirect role in intracellular protein trafficking and secreted-protein stability, says Dr. Van Meir. "These secreted targets will be helpful in better understanding how wt-p53 may modulate interactions of tumor cells with their environment and establishes p53 loss in tumors as a major trigger of changes in tumor-stroma interactions. A better understanding of these phenomena will improve our ability to devise new therapies for cancer."

The study was funded by the American Brain Tumor Association, the Pediatric Brain Tumor Foundation of the US, the National Institutes of Health, and the National Science Foundation. The team of researchers included Winship Cancer Institute and Emory University School of Medicine's Dr Erwin G. Van Meir, Fatima W. Khwaja, Ph.D., Paul Svoboda, Ph.D., Matthew Reed, Ph.D., Jan Pohl and Beata Pyrzynska, Ph.D.


Story Source:

The above story is based on materials provided by Emory University Health Sciences Center. Note: Materials may be edited for content and length.


Cite This Page:

Emory University Health Sciences Center. "Pioneering Study Looks At P53's Role In Tumor-stroma Interactions." ScienceDaily. ScienceDaily, 27 October 2006. <www.sciencedaily.com/releases/2006/10/061025180249.htm>.
Emory University Health Sciences Center. (2006, October 27). Pioneering Study Looks At P53's Role In Tumor-stroma Interactions. ScienceDaily. Retrieved October 25, 2014 from www.sciencedaily.com/releases/2006/10/061025180249.htm
Emory University Health Sciences Center. "Pioneering Study Looks At P53's Role In Tumor-stroma Interactions." ScienceDaily. www.sciencedaily.com/releases/2006/10/061025180249.htm (accessed October 25, 2014).

Share This



More Health & Medicine News

Saturday, October 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Texas Nurse Nina Pham Cured of Ebola

Texas Nurse Nina Pham Cured of Ebola

AFP (Oct. 25, 2014) — An American nurse who contracted Ebola while caring for a Liberian patient in Texas has been declared free of the virus and will leave the hospital. Duration: 01:01 Video provided by AFP
Powered by NewsLook.com
IKEA Desk Converts From Standing to Sitting With One Button

IKEA Desk Converts From Standing to Sitting With One Button

Buzz60 (Oct. 24, 2014) — IKEA is out with a new convertible desk that can convert from a sitting desk to a standing one with just the push of a button. Jen Markham explains. Video provided by Buzz60
Powered by NewsLook.com
Ebola Protective Suits Being Made in China

Ebola Protective Suits Being Made in China

AFP (Oct. 24, 2014) — A factory in China is busy making Ebola protective suits for healthcare workers and others fighting the spread of the virus. Duration: 00:38 Video provided by AFP
Powered by NewsLook.com
WHO: Millions of Ebola Vaccine Doses by 2015

WHO: Millions of Ebola Vaccine Doses by 2015

AP (Oct. 24, 2014) — The World Health Organization said on Friday that millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines would start being tested in March. (Oct. 24) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins